Mark Boaz

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

Maria Rosario Capeding, Ngoc Huu Tran, Sri Rezeki Hadinegoro et al. · The Lancet · 2014 · 959 citations

Vaccination, Vaccine Safety, Global Health +8

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

Luis Villar, Gustavo H. Dayan, José Luis Arredondo-Garcı́a et al. · New England Journal of Medicine · 2014 · 934 citations · Full text

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Melissa Simek, Wasima Rida, Frances Priddy et al. · Journal of Virology · 2009 · 577 citations · Full text

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

Nilu Goonetilleke, S. S. Moore, Len Dally et al. · Journal of Virology · 2006 · 236 citations · Full text

Presence of HIV-1 Gag-Specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection

Mark Boaz, Anele Waters, Shahed Murad et al. · The Journal of Immunology · 2002 · 234 citations · Full text